Temsirolimus-RCC-imaging

NCT01246817 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

51

Enrollment

OTHER

Sponsor class

Conditions

Renal Cell Cancer

Interventions

DRUG: Temsirolimus

Sponsor

Radboud University Medical Center